Attributes of individual DMTs: overview

Off-label disease-modifying therapies

Alemtuzumab

(Lemtrada)

Anti-CD20s (ocrelizumab, ofatumumab, rituximab, ublituximab)

(Ocrevus, Kesimpta, Bonspri, Briumvi, MabThera)

Cladribine

(Mavenclad)

Fumarates (dimethyl fumarate and diroximel fumarate)

(Tecfidera, Vumerity)

Glatiramer acetate (GA)

(Copaxone, Brabio)

HSCT/AHSCT

(Haematopoietic stem cell transplant/autologous haematopoietic stem cell transplant)

Interferon-beta (IFN-beta)

(Avonex, Betaferon, Betaseron, Extavia, Plegridy, Rebif)

Mitoxantrone

(Novantrone)

Natalizumab

(Tysabri, Tyruko)

Sphingosine 1-phosphate (S1P) modulators (fingolimod, siponimod, ozanimod, ponesimod)

(Gilenya, Mayzent, Zeposia, Ponvory)

Teriflunomide

(Aubagio)

MS-Selfie InfoCards: bite-sized information about DMTs for MS, for easy comparison.